Search PubMed⌕ Search

PubMed · 3059721

[Soft tissue sarcomas. Classifying and/or grading?].

Abstract

Grading of soft tissue sarcomas cannot substitute for their accurate classification. The latter, according to the historical typing of soft tissue tumors, as proposed by WHO (1969), has to be considered as presumptive for morphological grading. The parameters given for grading are subject to individual bias and artefacts. They are also influenced by the "histogenetic types" of tumors. To achieve some correlations between morphological grading and prognosis, grading parameters (atypia and mitotic activity) have to be weighted differently, according to tumor type. Immunohistochemical methods are helpful in accurate typing of tumors where classification is difficult. The future search will be concerned with more objective methods for grading, including immunohistochemical determination of proliferative markers (similar to Ki67) or flow-through cytophotometry. All efforts are oriented to achieving an optimal correlation between grading parameters on the one hand, and prognostic predictions on the other.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Meister. 1988. [Soft tissue sarcomas. Classifying and/or grading?].. https://pubmed.ncbi.nlm.nih.gov/3059721/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Long-term survival after multiple resections of a fibrosarcoma involving the lung and chest wall.

We report on the case of a 61-year-old male patient who developed a giant fibrosarcoma involving both the lung and chest wall. This patient underwent three extended resections including the chest wall in each case. Radiotherapy was administered after the last resection, when the tumor was obviously not completely removed. The patient lives a normal life with no signs of recurrence 5 years after his last resection. Multiple extended resections of large and aggressive sarcomas can result in long-term survival, with good quality of life, in adequately selected patients.

Fibrosarcoma↗

TNF-alpha suppresses IFN-gamma-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA.

Precise regulation of MHC class II gene expression is crucial for development and function of the immune system. Class II trans-activator (CIITA) has been shown to be required for constitutive and IFN-gamma-induced MHC class II transcription. TNF-alpha is commonly coexpressed with IFN-gamma during immune-mediated inflammatory responses and modulates IFN-gamma-stimulated MHC class II expression. The effect of TNF-alpha on MHC class II expression depends on cell type and cellular differentiation state. We show here that TNF-alpha suppresses IFN-gamma-induced CIITA mRNA accumulation, resulting in decreased MHC class II expression in human fibrosarcoma HT1080 cells. TNF-alpha also inhibits CIITA mRNA accumulation and protein expression in a tetracycline-regulated system without affecting promoter activity. CIITA mRNA, regulated by either IFN-gamma or tetracycline, was destabilized in the presence of TNF-alpha, suggesting that TNF-alpha utilizes a distinct mechanism to suppress MHC class II expression in HT1080 cells. Consistent with this interpretation, TNF-alpha blocked IFN-gamma-induced CIITA and MHC class II expression in mutant cells that are unresponsive to TGF-beta or IFN-beta. This is the first instance in which MHC class II expression is inhibited by destabilizing CIITA mRNA.

Fibrosarcoma↗